Analytical Data
-
基因名
GALNTL6
- Application
-
别名
GALNTL6；GALNT17；Polypeptide N-acetylgalactosaminyltransferase-like 6
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q49A17
-
表达区间
29-601aa
-
氨基酸序列
SLYKDKHLVKSAEPGEQQTFPLGLGDGQFYSWTDGLRRKDWHDYESIQKEAMRSRKGEHGKPYPLTEEDHDDSAYRENGFNIFVSNNIALERSLPDIRHANCKHKMYLERLPNTSIIIPFHNEGWTSLLRTIHSIINRTPGSLIAEIILVDDFSEREHLKDKLEEYMARFSKVRIVRTKKREGLIRTRLLGASMARGEVLTFLDSHCEVNVNWLPPLLNQIPLNHKTIVCPMIDVIDHNHFGYEAQAGDAMRGAFDWEMYYKRIPIPPELQRADPSDPFESPVMAGGLFAVDRKWFWELGGYDPGLEIWGGEQYEISFKVWMCGGEMFDVPCSRVGHIYRKYVPYKVPSGTSLARNLKRVAETWMDEFAEYIYQRRPEYRHLSTGDISAQKELRKQLKCKDFKWFMAAVAWDVPKYYPPVEPPPAAWGEIRNVAANLCVDSKHGATGTELRLDICVKDGSERTWSHEQLFTFGWREDIRPGEPLHTRKFCFDAISHNSPVTLYDCHGMKGNQLWGYRKDRTLFHPVSNSCMDCNHAEKKIFMARCDPLSETQQWIFEHINMTVLEKFNHHANS
-
分子量
70.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GALNTL6 (polypeptide N-acetylgalactosaminyltransferase-like 6) is a member of the GALNT family, which is known for its role in glycosylation processes, specifically in the addition of N-acetylgalactosamine (GalNAc) residues to serine or threonine residues in proteins. This post-translational modification plays a crucial role in various biological functions, including cell signaling, differentiation, and immune response. The expression of GALNTL6 has been implicated in several pathological conditions, including cancer, where its dysregulation may influence tumor progression and metastasis. Research into GALNTL6 has been propelled by its potential as a therapeutic target and its downstream effects on glycoprotein function. Recombinant GALNTL6 protein studies are critical for elucidating its enzymatic properties, substrate specificity, and biological implications. Understanding the molecular mechanisms by which GALNTL6 influences cellular processes can provide insights into its role in health and disease, paving the way for novel treatment strategies. Additionally, the recombinant protein may serve as a valuable tool for drug development and the study of glycosylation's impact on cellular interactions and signaling pathways. Overall, the investigation of GALNTL6 through recombinant protein approaches stands at the forefront of understanding its functional importance in human biology and potential clinical applications.
